Appraising ascorbic acid as a chemoprevention agent for acute myeloid leukaemia using Mendelian Randomisation by Sina A. Beer, Molly Went, Jessica M. Hislop, Richard Houlston, Martin Kaiser

Get full text

Mendelian randomization of immune cell phenotypes to discover potential drug targets for B-cell malignancy by Sina A. Beer, Molly Went, Charlie Mills, Codie Wood, Amit Sud, James M. Allan, Richard Houlston, Martin F. Kaiser

Get full text

SARS-CoV-2 immune responses in patients with multiple myeloma and lenalidomide maintenance therapy by Ioana Martac, Sina A. Beer, Aileen Schenk, Osama Ahmad, Claus-Philipp Maier, Claus-Philipp Maier, Gülay Demirel, Beate Preuß, Reinhild Klein, Anna M. P. Stanger, Britta Besemer, Luca Hensen, Claudia Lengerke

Get full text

PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma by Vanja Zeremski, Tobias R. Haage, Hanno M. Witte, Louisa Adolph, Sina A. Beer, Gerhard Behre, Benedikt Jacobs, Christoph Kahl, Chrysavgi Lalayanni, Jens Panse, Sotirios Papageorgiou, Marina P. Siakantaris, Jessica Schneider, Ulf Schnetzke, Alexander Schulz, Theodoros P. Vassilakopoulos, Jeanette Walter, Dimitrios Mougiakakos

Get full text